Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data.

MLA

Bergagnini-Kolev, Mackenzie, et al. “Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data.” The AAPS Journal, vol. 25, no. 4, June 2023, p. 62. EBSCOhost, https://doi.org/10.1208/s12248-023-00828-z.

APA

Bergagnini-Kolev, M., Kane, K., Templeton, I. E., & Curran, A. K. (2023). Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data. The AAPS Journal, 25(4), 62. https://doi.org/10.1208/s12248-023-00828-z

Chicago

Bergagnini-Kolev, Mackenzie, Katie Kane, Ian E Templeton, and Aidan K Curran. 2023. “Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data.” The AAPS Journal 25 (4): 62. doi:10.1208/s12248-023-00828-z.